Waystar (WAY) Stock Price, News & Analysis

Company Overview

Waystar Holding Corp. is a healthcare payments technology company that provides cloud-based software for managing administrative and financial processes across the healthcare system. Its platform connects healthcare providers, health plans and patients, helping organizations simplify complex transactions and improve the efficiency of the revenue cycle.

The company’s products and services include patient eligibility and coverage verification, claims management and submission, payment processing, prior authorization, denial and appeal management, patient billing, and related workflow automation. Waystar’s technology is designed to reduce manual administrative work, support cleaner claims, and help healthcare organizations collect and reconcile payments.

Waystar traces its history to the combination of healthcare technology businesses including Navicure and ZirMed, and operates primarily in the United States healthcare market. Matthew Hawkins serves as the company’s chief executive officer. Waystar began trading publicly on the Nasdaq under the symbol WAY in 2024.

Key Stats

• Today's Range: $23.09 to $23.70
• 50-Day Range: $20.79 to $26.24
• 52-Week Range: $17.26 to $40.35
• Volume: 1.73 million shs
• Average Volume: 1.88 million shs
• Market Capitalization: $4.50 billion
• P/E Ratio: 33.53
• Dividend Yield: N/A
• Price Target: $35.14
• Consensus Rating: Moderate Buy

Waystar Stock Analysis - MarketRank™

Waystar scored higher than 94% of companies evaluated by MarketBeat, and ranked 20th out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Waystar has received a consensus rating of Moderate Buy. The company's average rating score is 2.96, and is based on 2 strong buy ratings, 20 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Waystar has a consensus price target of $35.14, representing about 49.7% upside from its current price of $23.47.

Amount of Analyst Coverage

Waystar has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 14.29%

Earnings Growth

Earnings for Waystar are expected to grow by 14.29% in the coming year, from $1.47 to $1.68 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Waystar is 33.53, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.19.

Price to Earnings Ratio vs. Sector

The P/E ratio of Waystar is 33.53, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.25.

Price to Earnings Growth Ratio

Waystar has a PEG Ratio of 0.91. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Waystar has a P/B Ratio of 1.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.63% of the float of Waystar has been sold short.

Short Interest Ratio / Days to Cover

Waystar has a short interest ratio ("days to cover") of 6.05.

Change versus previous month

Short interest in Waystar has recently increased by 3.49%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Waystar does not currently pay a dividend.

Dividend Growth

Waystar does not have a long track record of dividend growth.

News and Social Media

• Score: 4.0 / 5
• News Sentiment: 1.45

News Sentiment

Waystar has a news sentiment score of 1.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Waystar this week, compared to 5 articles on an average week.

Search Interest

Only 2 people have searched for WAY on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days.

MarketBeat Follows

3 people have added Waystar to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Waystar insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,206,524.00 in company stock.

Percentage Held by Insiders

3.50% of the stock of Waystar is held by insiders.

Percentage Held by Institutions

Waystar has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 9/13/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:WAY
• Previous Symbol: NASDAQ:WAY
• CIK: 1990354
• Web: www.waystar.com
• Phone: (844) 492-9782
• Fax: N/A
• Employees: 1,700
• Year Founded: 2017

Price Target and Rating

• Average Price Target for Waystar: $35.14
• High Price Target: $48.00
• Low Price Target: $27.00
• Potential Upside/Downside: +49.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.96
• Research Coverage: 25 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.70
• Trailing P/E Ratio: 33.53
• Forward P/E Ratio: 15.97
• P/E Growth: 0.91
• Net Income: $112.09 million
• Net Margins: 11.18%
• Pretax Margin: 16.18%
• Return on Equity: 7.03%
• Return on Assets: 4.75%

Debt

• Debt-to-Equity Ratio: 0.36
• Current Ratio: 1.85
• Quick Ratio: 1.85

Sales & Book Value

• Annual Sales: $1.10 billion
• Price / Sales: 4.09
• Cash Flow: $1.95 per share
• Price / Cash Flow: 12.04
• Book Value: $20.27 per share
• Price / Book: 1.16

Miscellaneous

• Outstanding Shares: 191,750,000
• Free Float: 185,037,000
• Market Cap: $4.50 billion
• Optionable: Optionable
• Beta: 0.16